You might try a cancer vaccine company. I'm sure they'd
appreciate finding more uses for their intermediate products. The
problem with TAA is that so far, it is patient-specific and in fact
you have to determine the pre-metastased, original cancer (IMPATH?
Hailing IMPATH, hello?) that is responsible, and then you bombard the
immune system with huge quantities of the stuff so it begins to
respond.
- = -
Vasos-Peter John Panagiotopoulos II, Columbia'81+, Bioengineer-Financier, NYC
BachMozart ReaganQuayle EvrytanoKastorian http://WWW.Dorsai.Org/~vjp2
vjp2@{MCIMail.Com|CompuServe.Com|Dorsai.Org}
---{Nothing herein constitutes advice. Everything fully disclaimed.}---
